Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.

Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stoger, H; Stotz, M; Gerger, A; Pichler, M.

Cancers (Basel). 2020 May 4;12(5):1154. doi: 10.3390/cancers12051154.

https://pubmed.ncbi.nlm.nih.gov/32375339/